PET在肿瘤方面应用的成本效益分析

顾爱春; 黄钢

PET在肿瘤方面应用的成本效益分析

顾爱春 , 黄钢

文章导航 > 国际放射医学核医学杂志 > 2006, 30 > 2: (65-68)

引用本文:

Citation:

PET在肿瘤方面应用的成本效益分析

顾爱春¹,
黄钢²

1. 200127 上海, 上海第二医科大学附属仁济医院核医学科;
2. 200127 上海, 上海第二医科大学临床核医学研究所
中图分类号: F224.5;R817.4

Cost-effective analysis of PET in oncology

GU Ai-chun¹,
HUANG Gang²

1. Department of Nuclear Medicine, Renji Hospital, Shanghai Second Medical University, Shanghai 200127, China;
2. Institute of Nuclear Medicine, Shanghai Second Medical University, Shanghai 200127, China
CLC number: F224.5;R817.4

摘要: PET技术的发展对肿瘤的诊断、分期、指导治疗产生了重要的影响。通过成本效益分析可以有效地从经济学的角度对PET的使用效率进行评价,达到最大程度节省医疗资源的目的。本文主要介绍了成本效益分析的方法以及PET在肿瘤方面的成本效益分析的现状。
- 决策支持技术 /
- 体层摄影术,发射型计算机 /
- 肿瘤 /
- 成本效益分析
Abstract: The development of PET has greatly influenced the diagnosis, staging and treatment in many kinds of cancers. The medical resources can be saved through cost-effective analysis of PET in oncology. This article mainly introduces the method of cost-effective analysis and the present state of the cost-effective analysis of PET in oncology.
- Decisiom support techniques /
- Tomography,emission-computed /
- Oncology /
- Cost-effective analysis
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Valk PE,Pounds TR,Tesar RD,et al.Cost-effectiveness of PET imaging in clinical oncology.Nucl Med Biol,1996,23(6):737-743.
[2]	Gambhir SS,Shepherd JE,Shah BD,et al.Analytical decision model for the cost-effective management of solitary pulmonary nodules.J Clin Oncol,1998,16(6):2113-2125.
[3]	Miles KA.An approach to demonstrating cost-effectiveness of diagnostic imaging modalities in Australia illustrated by PET.Austr Radiol,2001,45(1):9-18.
[4]	Keith CJ,Miles KA,Griffiths MR,et al.Solitary pulmonary nodules:accuracy and cost-effectiveness of sodium iodide FDG-PET using Australian data.Eur J Nucl Med Mol Imaging,2002,29(8):1016-1023.
[5]	Kosuda S,Ichihara K,Watanabe M,et al.Decision-tree sensitivity analysis for cost-effectiveness of FDG-PET in patients with pulmonary nodules(non-small cell lung carcinoma) in Japan.Chest,2000,117(2):346-353.
[6]	Dietlein M,Weber K,Gandiour A,et al.Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules:a decision analysis based on cost reimbursement in Germany.Eur J Nucl Med,2000,27(10):1441-1456.
[7]	Gugiatti A,Grimaldi A,Rossetti C,et al.Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-celllung-cancer in Italy.Q J Nucl Med,2004,48(1):49-61.
[8]	Gambhir SS,Hoh CK,Phelps ME,et al.Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.J Nucl Med,1996,37(9):1428-1436.
[9]	Scott WJ,Shelpherd J,Gambhir SS.Cost-effectiveness of FDG-PET for staging non-small-cell lung carcinoma:a decision analysis.Ann Thorac Surg,1998,66(6):1876-1883.
[10]	Yap KK,Yap KS,Byrne AJ,et al.Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer.Eur J Nucl Med Mol Imaging,2005,32(9):1033-1040.
[11]	Alzahouri K,Lejeune C,Woronoff-Lemsi MC,et al.Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective.Clin Radiol,2005,60(4):479-492.
[12]	Sloka JS,Hollett PD,Mathews M.Cost-effectiveness of positron emission tomography for non-small cell lung carcinoma in Canada.Med Sci Monit,2004,10(5):MT73-MT80.
[13]	Nguyen VH,Peloquin S,Lacasse Y.Cost-effectiveness of positron emission tomography for the management of potentially operable non-small cell lung cancer in Quebec.Can Respir J,2005,12(1):19-25.
[14]	Kosuda S,Ichihara K,Watanabe M,et al.Decision-tree sensitivity analysis for cost-effectiveness of whole-body FDG PET in the management of patients with non-small cell lung carcinoma in Japan.Ann Nucl Med,2002,16(4):263-271.
[15]	Dietlein M,Weber K,Gandiour A,et al.Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer:priority for a PET-based strategy after nodal-negative CT results.Eur J Nucl Med,2000,27(11):1598-1609.
[16]	Zubeldia JM,Bednarczyk EM,Baker JG,et al.The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases.Cancer Biother Radiopharm,2005,20(4):450-456.
[17]	Sloka JS,Hollett PD.Cost effectiveness of positron emission tomography in Canada.Med Sci Monit,2005,11(10):PH1-PH6.
[18]	Hollenbeak CS,Lowe VJ,Stack BC Jr.The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the NO neck.Cancer,2001,92(9):2341-2348
[19]	Bongers V,Hobbelink MG,van Rijk PP,et al.Cost-effectiveness ofdual-head ¹⁸F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer.Cancer Biother Radiopharm,2002,17(3):303-306.
[20]	Hoh CK,Glaspy J,Rosen P,et al.Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.J Nucl Med,1997,38(3):343-348.
[21]	Klose T,Leidl R,Buchmann I,et al.Primary staging of lymphomas:cost-effectiveness of FDG-PET versus computed tomography.Eur J Nucl Med,2000,27(10):1457-1464.
[22]	Sloka JS,Hollett PD,Mathews M.Cost-effectiveness of positron emission tomography in breast cancer.Mol Imaging Biol,2005,7(5):351-360.
[23]	Tsushima Y,Endo K.Analysis models to assess cost effectiveness of the four strategies for the work-up of solitary pulmonary nodules.Med Sci Monit,2004,10(5):MT65-MT72.

[1]	夏伟 , 罗全勇 , 袁志斌 . PET-CT在肿瘤放射治疗中的应用. 国际放射医学核医学杂志, 2006, 30(6): 331-335.
[2]	陈香 , 赵晋华 . PET及PET-CT在监测肿瘤治疗效果中的价值. 国际放射医学核医学杂志, 2007, 31(6): 354-358.
[3]	吕慧清 , 张中民 , 吕仲虹 . ¹⁸F-氟代脱氧葡萄糖PET在恶性肿瘤适形放射治疗中的价值. 国际放射医学核医学杂志, 2006, 30(6): 335-337.
[4]	张佳胤 , 李彪 . 正电子药物在肿瘤诊断中的进展. 国际放射医学核医学杂志, 2006, 30(1): 30-35.
[5]	宋少莉 , 黄钢 . ¹⁸F-氟脱氧葡萄糖PET监测实体瘤放化疗疗效的应用进展. 国际放射医学核医学杂志, 2007, 31(5): 284-288.
[6]	李小东 , 张遵城 , 董华 , 董萍 , 赵洪刚 , 郭永涛 . 核医学技术在肿瘤治疗中的应用与进展. 国际放射医学核医学杂志, 2006, 30(3): 163-167.
[7]	叶慧 , 莫逸 , 谢爱民 , 彭翔 . ¹⁸F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究. 国际放射医学核医学杂志, 2008, 32(3): 147-150.
[8]	川玲 . 双探头符合线路技术和检测肿瘤的价值. 国际放射医学核医学杂志, 2002, 26(1): 4-7.
[9]	杨卫东 , 朱承谟 . 肿瘤反义显像技术中的若干问题. 国际放射医学核医学杂志, 1998, 22(6): 244-247.
[10]	袁杰 , 詹松华 . 磁共振弹性成像技术在肿瘤中的应用及研究进展. 国际放射医学核医学杂志, 2019, 43(2): 171-175. doi: 10.3760/cma.j.issn.1673-4114.2019.01.013